Overview

Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic profile, safety, and tolerability of ramelteon in adolescents with insomnia, children with Attention Deficit Hyperactivity Disorder (ADHD) associated with insomnia and gender- and race-matched healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda